Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

Rapid, multiplexed, whole genome and plasmid sequencing of foodborne pathogens using long-read nanopore technology.

Taylor TL, Volkening JD, DeJesus E, Simmons M, Dimitrov KM, Tillman GE, Suarez DL, Afonso CL.

Sci Rep. 2019 Nov 8;9(1):16350. doi: 10.1038/s41598-019-52424-x.

2.

Mechanisms underlying the production effect for singing.

Quinlan CK, Taylor TL.

Can J Exp Psychol. 2019 Dec;73(4):254-264. doi: 10.1037/cep0000179. Epub 2019 Aug 8.

PMID:
31393154
3.

Virulent Newcastle disease viruses from chicken origin are more pathogenic and transmissible to chickens than viruses normally maintained in wild birds.

Ferreira HL, Taylor TL, Dimitrov KM, Sabra M, Afonso CL, Suarez DL.

Vet Microbiol. 2019 Aug;235:25-34. doi: 10.1016/j.vetmic.2019.06.004. Epub 2019 Jun 5.

4.

Genomic comparison of Newcastle disease viruses isolated in Nigeria between 2002 and 2015 reveals circulation of highly diverse genotypes and spillover into wild birds.

Welch CN, Shittu I, Abolnik C, Solomon P, Dimitrov KM, Taylor TL, Williams-Coplin D, Goraichuk IV, Meseko CA, Ibu JO, Gado DA, Joannis TM, Afonso CL.

Arch Virol. 2019 Aug;164(8):2031-2047. doi: 10.1007/s00705-019-04288-9. Epub 2019 May 23.

PMID:
31123963
5.

Presence of Newcastle disease viruses of sub-genotypes Vc and VIn in backyard chickens and in apparently healthy wild birds from Mexico in 2017.

Ferreira HL, Taylor TL, Absalon AE, Dimitrov KM, Cortés-Espinosa DV, Butt SL, Marín-Cruz JL, Goraichuk IV, Volkening JD, Suarez DL, Afonso CL.

Virus Genes. 2019 Aug;55(4):479-489. doi: 10.1007/s11262-019-01663-1. Epub 2019 Apr 12.

PMID:
30976951
6.

Pathogenicity and transmission of virulent Newcastle disease virus from the 2018-2019 California outbreak and related viruses in young and adult chickens.

Dimitrov KM, Ferreira HL, Pantin-Jackwood MJ, Taylor TL, Goraichuk IV, Crossley BM, Killian ML, Bergeson NH, Torchetti MK, Afonso CL, Suarez DL.

Virology. 2019 May;531:203-218. doi: 10.1016/j.virol.2019.03.010. Epub 2019 Mar 22.

PMID:
30928699
7.

Discovery of Branebrutinib (BMS-986195): A Strategy for Identifying a Highly Potent and Selective Covalent Inhibitor Providing Rapid in Vivo Inactivation of Bruton's Tyrosine Kinase (BTK).

Watterson SH, Liu Q, Beaudoin Bertrand M, Batt DG, Li L, Pattoli MA, Skala S, Cheng L, Obermeier MT, Moore R, Yang Z, Vickery R, Elzinga PA, Discenza L, D'Arienzo C, Gillooly KM, Taylor TL, Pulicicchio C, Zhang Y, Heimrich E, McIntyre KW, Ruan Q, Westhouse RA, Catlett IM, Zheng N, Chaudhry C, Dai J, Galella MA, Tebben AJ, Pokross M, Li J, Zhao R, Smith D, Rampulla R, Allentoff A, Wallace MA, Mathur A, Salter-Cid L, Macor JE, Carter PH, Fura A, Burke JR, Tino JA.

J Med Chem. 2019 Apr 11;62(7):3228-3250. doi: 10.1021/acs.jmedchem.9b00167. Epub 2019 Mar 29.

PMID:
30893553
8.

Identification of Imidazo[1,2-b]pyridazine Derivatives as Potent, Selective, and Orally Active Tyk2 JH2 Inhibitors.

Liu C, Lin J, Moslin R, Tokarski JS, Muckelbauer J, Chang C, Tredup J, Xie D, Park H, Li P, Wu DR, Strnad J, Zupa-Fernandez A, Cheng L, Chaudhry C, Chen J, Chen C, Sun H, Elzinga P, D'arienzo C, Gillooly K, Taylor TL, McIntyre KW, Salter-Cid L, Lombardo LJ, Carter PH, Aranibar N, Burke JR, Weinstein DS.

ACS Med Chem Lett. 2019 Feb 21;10(3):383-388. doi: 10.1021/acsmedchemlett.9b00035. eCollection 2019 Mar 14.

9.

Identification and Preclinical Pharmacology of ((1 R,3 S)-1-Amino-3-(( S)-6-(2-methoxyphenethyl)-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopentyl)methanol (BMS-986166): A Differentiated Sphingosine-1-phosphate Receptor 1 (S1P1) Modulator Advanced into Clinical Trials.

Gilmore JL, Xiao HY, Dhar TGM, Yang MG, Xiao Z, Xie J, Lehman-McKeeman LD, Gong L, Sun H, Lecureux L, Chen C, Wu DR, Dabros M, Yang X, Taylor TL, Zhou XD, Heimrich EM, Thomas R, McIntyre KW, Borowski V, Warrack BM, Li Y, Shi H, Levesque PC, Yang Z, Marino AM, Cornelius G, D'Arienzo CJ, Mathur A, Rampulla R, Gupta A, Pragalathan B, Shen DR, Cvijic ME, Salter-Cid LM, Carter PH, Dyckman AJ.

J Med Chem. 2019 Mar 14;62(5):2265-2285. doi: 10.1021/acs.jmedchem.8b01695. Epub 2019 Mar 6.

PMID:
30785748
10.

MinION sequencing to genotype US strains of infectious laryngotracheitis virus.

Spatz SJ, Garcia M, Riblet S, Ross TA, Volkening JD, Taylor TL, Kim T, Afonso CL.

Avian Pathol. 2019 Jun;48(3):255-269. doi: 10.1080/03079457.2019.1579298. Epub 2019 Mar 11.

PMID:
30722676
11.

Rapid virulence prediction and identification of Newcastle disease virus genotypes using third-generation sequencing.

Butt SL, Taylor TL, Volkening JD, Dimitrov KM, Williams-Coplin D, Lahmers KK, Miller PJ, Rana AM, Suarez DL, Afonso CL, Stanton JB.

Virol J. 2018 Nov 22;15(1):179. doi: 10.1186/s12985-018-1077-5.

12.

Selection for encoding: No evidence of better endogenous orienting following forget than following remember instructions.

Rubinfeld LM, Taylor TL, Hamm JP.

Atten Percept Psychophys. 2019 Jan;81(1):237-252. doi: 10.3758/s13414-018-1587-7. Erratum in: Atten Percept Psychophys. 2019 Jul;81(5):1741.

PMID:
30194621
13.

A grand memory for forgetting: Directed forgetting across contextual changes.

Taylor TL, Hamm JP.

Acta Psychol (Amst). 2018 Jul;188:39-54. doi: 10.1016/j.actpsy.2018.05.009. Epub 2018 May 29.

PMID:
29857288
14.

Remember to blink: Reduced attentional blink following instructions to forget.

Taylor TL.

Atten Percept Psychophys. 2018 Aug;80(6):1489-1503. doi: 10.3758/s13414-018-1528-5.

PMID:
29691764
15.

Whole-genome sequencing of genotype VI Newcastle disease viruses from formalin-fixed paraffin-embedded tissues from wild pigeons reveals continuous evolution and previously unrecognized genetic diversity in the U.S.

He Y, Taylor TL, Dimitrov KM, Butt SL, Stanton JB, Goraichuk IV, Fenton H, Poulson R, Zhang J, Brown CC, Ip HS, Isidoro-Ayza M, Afonso CL.

Virol J. 2018 Jan 12;15(1):9. doi: 10.1186/s12985-017-0914-2.

16.

Item-method directed forgetting: Effects at retrieval?

Taylor TL, Cutmore L, Pries L.

Acta Psychol (Amst). 2018 Feb;183:116-123. doi: 10.1016/j.actpsy.2017.12.004. Epub 2017 Dec 22.

PMID:
29275948
17.

Decomposing item-method directed forgetting of emotional pictures: Equivalent costs and no benefits.

Taylor TL, Quinlan CK, Vullings KCH.

Mem Cognit. 2018 Jan;46(1):132-147. doi: 10.3758/s13421-017-0751-y.

PMID:
29214552
18.

Bruton's tyrosine kinase inhibitor BMS-986142 in experimental models of rheumatoid arthritis enhances efficacy of agents representing clinical standard-of-care.

Gillooly KM, Pulicicchio C, Pattoli MA, Cheng L, Skala S, Heimrich EM, McIntyre KW, Taylor TL, Kukral DW, Dudhgaonkar S, Nagar J, Banas D, Watterson SH, Tino JA, Fura A, Burke JR.

PLoS One. 2017 Jul 24;12(7):e0181782. doi: 10.1371/journal.pone.0181782. eCollection 2017.

19.

Repeated Challenge with Virulent Newcastle Disease Virus Does Not Decrease the Efficacy of Vaccines.

Taylor TL, Miller PJ, Olivier TL, Montiel E, Cardenas Garcia S, Dimitrov KM, Williams-Coplin D, Afonso CL.

Avian Dis. 2017 Jun;61(2):245-249. doi: 10.1637/11555-120816-ResNote.1.

PMID:
28665733
20.

Genome-wide analysis reveals class and gene specific codon usage adaptation in avian paramyxoviruses 1.

Taylor TL, Dimitrov KM, Afonso CL.

Infect Genet Evol. 2017 Jun;50:28-37. doi: 10.1016/j.meegid.2017.02.004. Epub 2017 Feb 9.

PMID:
28189889
21.

Asymmetric Hydroboration Approach to the Scalable Synthesis of ((1R,3S)-1-Amino-3-((R)-6-hexyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopentyl)methanol (BMS-986104) as a Potent S1P1 Receptor Modulator.

Yang MG, Xiao Z, Dhar TG, Xiao HY, Gilmore JL, Marcoux D, Xie JH, McIntyre KW, Taylor TL, Borowski V, Heimrich E, Li YW, Feng J, Fernandes A, Yang Z, Balimane P, Marino AM, Cornelius G, Warrack BM, Mathur A, Wu DR, Li P, Gupta A, Pragalathan B, Shen DR, Cvijic ME, Lehman-McKeeman LD, Salter-Cid L, Barrish JC, Carter PH, Dyckman AJ.

J Med Chem. 2016 Dec 22;59(24):11138-11147. doi: 10.1021/acs.jmedchem.6b01433. Epub 2016 Dec 7.

PMID:
28002964
22.

Identification of potent tricyclic prodrug S1P1 receptor modulators.

Marcoux D, Xiao HY, Murali Dhar TG, Xie J, Lehman-McKeeman LD, Wu DR, Dabros M, Yang X, Taylor TL, Zhou XD, Heimrich EM, Thomas R, McIntyre KW, Shi H, Levesque PC, Sun H, Yang Z, Marino AM, Cornelius G, D'Arienzo CJ, Gupta A, Pragalathan B, Rampulla R, Mathur A, Shen DR, Cvijic ME, Salter-Cid L, Lombardo LJ, Carter PH, Dyckman AJ.

Medchemcomm. 2016 Nov 25;8(4):725-729. doi: 10.1039/c6md00539j. eCollection 2017 Apr 1.

23.

Identification of Tricyclic Agonists of Sphingosine-1-phosphate Receptor 1 (S1P1) Employing Ligand-Based Drug Design.

Xiao HY, Watterson SH, Langevine CM, Srivastava AS, Ko SS, Zhang Y, Cherney RJ, Guo WW, Gilmore JL, Sheppeck JE 2nd, Wu DR, Li P, Ramasamy D, Arunachalam P, Mathur A, Taylor TL, Shuster DJ, McIntyre KW, Shen DR, Yarde M, Cvijic ME, Marino AM, Balimane PV, Yang Z, Banas DM, Cornelius G, D'Arienzo CJ, Warrack BM, Lehman-McKeeman L, Salter-Cid LM, Xie J, Barrish JC, Carter PH, Dyckman AJ, Dhar TG.

J Med Chem. 2016 Nov 10;59(21):9837-9854. Epub 2016 Oct 20.

PMID:
27726358
24.

Discovery of 6-Fluoro-5-(R)-(3-(S)-(8-fluoro-1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)-2-methylphenyl)-2-(S)-(2-hydroxypropan-2-yl)-2,3,4,9-tetrahydro-1H-carbazole-8-carboxamide (BMS-986142): A Reversible Inhibitor of Bruton's Tyrosine Kinase (BTK) Conformationally Constrained by Two Locked Atropisomers.

Watterson SH, De Lucca GV, Shi Q, Langevine CM, Liu Q, Batt DG, Beaudoin Bertrand M, Gong H, Dai J, Yip S, Li P, Sun D, Wu DR, Wang C, Zhang Y, Traeger SC, Pattoli MA, Skala S, Cheng L, Obermeier MT, Vickery R, Discenza LN, D'Arienzo CJ, Zhang Y, Heimrich E, Gillooly KM, Taylor TL, Pulicicchio C, McIntyre KW, Galella MA, Tebben AJ, Muckelbauer JK, Chang C, Rampulla R, Mathur A, Salter-Cid L, Barrish JC, Carter PH, Fura A, Burke JR, Tino JA.

J Med Chem. 2016 Oct 13;59(19):9173-9200. Epub 2016 Sep 19.

PMID:
27583770
25.

A preliminary investigation into the neural basis of the production effect.

Hassall CD, Quinlan CK, Turk DJ, Taylor TL, Krigolson OE.

Can J Exp Psychol. 2016 Jun;70(2):139-46. doi: 10.1037/cep0000093.

PMID:
27244355
26.

Identification and Preclinical Pharmacology of BMS-986104: A Differentiated S1P1 Receptor Modulator in Clinical Trials.

Dhar TG, Xiao HY, Xie J, Lehman-McKeeman LD, Wu DR, Dabros M, Yang X, Taylor TL, Zhou XD, Heimrich EM, Thomas R, McIntyre KW, Warrack B, Shi H, Levesque PC, Zhu JL, Hennan J, Balimane P, Yang Z, Marino AM, Cornelius G, D'Arienzo CJ, Mathur A, Shen DR, Cvijic ME, Salter-Cid L, Barrish JC, Carter PH, Dyckman AJ.

ACS Med Chem Lett. 2016 Jan 19;7(3):283-8. doi: 10.1021/acsmedchemlett.5b00448. eCollection 2016 Mar 10.

27.

Quality of care and its determinants in longer term mental health facilities across Europe; a cross-sectional analysis.

Killaspy H, Cardoso G, White S, Wright C, Caldas de Almeida JM, Turton P, Taylor TL, Schützwohl M, Schuster M, Cervilla JA, Brangier P, Raboch J, Kalisova L, Onchev G, Alexiev S, Mezzina R, Ridente P, Wiersma D, Visser E, Kiejna A, Adamowski T, Ploumpidis D, Gonidakis F, King M.

BMC Psychiatry. 2016 Feb 11;16:31. doi: 10.1186/s12888-016-0737-5.

28.

The representational consequences of intentional forgetting: Impairments to both the probability and fidelity of long-term memory.

Fawcett JM, Lawrence MA, Taylor TL.

J Exp Psychol Gen. 2016 Jan;145(1):56-81. doi: 10.1037/xge0000128.

29.

Selection for encoding: No evidence of greater attentional capture following forget than remember instructions.

Taylor TL, Hamm JP.

Atten Percept Psychophys. 2016 Jan;78(1):168-86. doi: 10.3758/s13414-015-0984-4.

PMID:
26404529
30.

Discovery of ((4-(5-(Cyclopropylcarbamoyl)-2-methylphenylamino)-5-methylpyrrolo[1,2-f][1,2,4]triazine-6-carbonyl)(propyl)carbamoyloxy)methyl-2-(4-(phosphonooxy)phenyl)acetate (BMS-751324), a Clinical Prodrug of p38α MAP Kinase Inhibitor.

Liu C, Lin J, Hynes J, Wu H, Wrobleski ST, Lin S, Dhar TG, Vrudhula VM, Sun JH, Chao S, Zhao R, Wang B, Chen BC, Everlof G, Gesenberg C, Zhang H, Marathe PH, McIntyre KW, Taylor TL, Gillooly K, Shuster DJ, McKinnon M, Dodd JH, Barrish JC, Schieven GL, Leftheris K.

J Med Chem. 2015 Oct 8;58(19):7775-84. doi: 10.1021/acs.jmedchem.5b00839. Epub 2015 Sep 22.

PMID:
26359680
31.

Memory instruction interacts with both visual and motoric inhibition of return.

Thompson KM, Taylor TL.

Atten Percept Psychophys. 2015 Apr;77(3):804-18. doi: 10.3758/s13414-014-0820-2.

PMID:
25592783
32.

"I never forget a face, but in your case I'll be glad to make an exception": Intentional forgetting of emotional faces.

Quinlan CK, Taylor TL.

Can J Exp Psychol. 2014 Sep;68(3):212-21. doi: 10.1037/cep0000024.

PMID:
25383479
33.

Effects of memory instruction on attention and information processing: Further investigation of inhibition of return in item-method directed forgetting.

Thompson KM, Hamm JP, Taylor TL.

Atten Percept Psychophys. 2014 Feb;76(2):322-34. doi: 10.3758/s13414-013-0584-0.

PMID:
24282134
34.

Event-method directed forgetting: forgetting a video segment is more effortful than remembering it.

Fawcett JM, Taylor TL, Nadel L.

Acta Psychol (Amst). 2013 Oct;144(2):332-43. doi: 10.1016/j.actpsy.2013.07.005. Epub 2013 Aug 7.

PMID:
23933003
35.

Enhancing the production effect in memory.

Quinlan CK, Taylor TL.

Memory. 2013;21(8):904-15. doi: 10.1080/09658211.2013.766754. Epub 2013 Feb 5.

PMID:
23384885
36.

Intentional forgetting diminishes memory for continuous events.

Fawcett JM, Taylor TL, Nadel L.

Memory. 2013;21(6):675-94. doi: 10.1080/09658211.2012.748078. Epub 2013 Jan 10.

PMID:
23301998
37.

Psychometric properties of the Mental Health Recovery Star.

Killaspy H, White S, Taylor TL, King M.

Br J Psychiatry. 2012 Jul;201(1):65-70. doi: 10.1192/bjp.bp.111.107946.

PMID:
22753854
38.

Interplay of the production and picture superiority effects: a signal detection analysis.

Fawcett JM, Quinlan CK, Taylor TL.

Memory. 2012;20(7):655-66. doi: 10.1080/09658211.2012.693510. Epub 2012 Jun 26.

PMID:
22734687
39.

Does an instruction to forget enhance memory for other presented items?

Taylor TL, Fawcett JM.

Conscious Cogn. 2012 Sep;21(3):1186-97. doi: 10.1016/j.concog.2012.05.002. Epub 2012 Jun 9.

PMID:
22687390
40.

Quality of longer term mental health facilities in Europe: validation of the quality indicator for rehabilitative care against service users' views.

Killaspy H, White S, Wright C, Taylor TL, Turton P, Kallert T, Schuster M, Cervilla JA, Brangier P, Raboch J, Kalisova L, Onchev G, Alexiev S, Mezzina R, Ridente P, Wiersma D, Visser E, Kiejna A, Piotrowski P, Ploumpidis D, Gonidakis F, Caldas-de-Almeida JM, Cardoso G, King M.

PLoS One. 2012;7(6):e38070. doi: 10.1371/journal.pone.0038070. Epub 2012 Jun 4.

41.

Horseshoe abscess associated with acute carpal tunnel syndrome: somebody wake up the hand surgeon.

Simon DA, Taylor TL.

CJEM. 2012 Mar;14(2):124-7. doi: 10.2310/8000.2011.110364.

PMID:
22554444
42.

The control of working memory resources in intentional forgetting: evidence from incidental probe word recognition.

Fawcett JM, Taylor TL.

Acta Psychol (Amst). 2012 Jan;139(1):84-90. doi: 10.1016/j.actpsy.2011.10.001. Epub 2011 Oct 26.

PMID:
22032824
43.

Characterization of BMS-911543, a functionally selective small-molecule inhibitor of JAK2.

Purandare AV, McDevitt TM, Wan H, You D, Penhallow B, Han X, Vuppugalla R, Zhang Y, Ruepp SU, Trainor GL, Lombardo L, Pedicord D, Gottardis MM, Ross-Macdonald P, de Silva H, Hosbach J, Emanuel SL, Blat Y, Fitzpatrick E, Taylor TL, McIntyre KW, Michaud E, Mulligan C, Lee FY, Woolfson A, Lasho TL, Pardanani A, Tefferi A, Lorenzi MV.

Leukemia. 2012 Feb;26(2):280-8. doi: 10.1038/leu.2011.292. Epub 2011 Oct 21.

PMID:
22015772
44.

Activation of matrix metalloproteinases following anti-Aβ immunotherapy; implications for microhemorrhage occurrence.

Wilcock DM, Morgan D, Gordon MN, Taylor TL, Ridnour LA, Wink DA, Colton CA.

J Neuroinflammation. 2011 Sep 9;8:115. doi: 10.1186/1742-2094-8-115.

45.

Tag, you're it: tagging as an alternative to yes/no recognition in item method directed forgetting.

Thompson KM, Fawcett JM, Taylor TL.

Acta Psychol (Amst). 2011 Sep;138(1):171-5. doi: 10.1016/j.actpsy.2011.06.001. Epub 2011 Jul 16.

PMID:
21762868
46.

Configuration and rearrangement of the human GAGE gene clusters.

Killen MW, Taylor TL, Stults DM, Jin W, Wang LL, Moscow JA, Pierce AJ.

Am J Transl Res. 2011 May 15;3(3):234-42. Epub 2011 May 8.

47.

Larger IOR effects following forget than following remember instructions depend on exogenous attentional withdrawal and target localization.

Taylor TL, Fawcett JM.

Atten Percept Psychophys. 2011 Aug;73(6):1790-814. doi: 10.3758/s13414-011-0146-2.

PMID:
21618066
48.

Evaluation of the physical and in vitro protective activity of three synthetic peptides derived from the pro- and mature GDNF sequence.

Kelps KA, Turchan-Cholewo J, Hascup ER, Taylor TL, Gash DM, Gerhardt GA, Bradley LH.

Neuropeptides. 2011 Jun;45(3):213-8. doi: 10.1016/j.npep.2011.03.003. Epub 2011 Apr 19.

49.

The development of the Quality Indicator for Rehabilitative Care (QuIRC): a measure of best practice for facilities for people with longer term mental health problems.

Killaspy H, White S, Wright C, Taylor TL, Turton P, Schützwohl M, Schuster M, Cervilla JA, Brangier P, Raboch J, Kališová L, Onchev G, Alexiev S, Mezzina R, Ridente P, Wiersma D, Visser E, Kiejna A, Adamowski T, Ploumpidis D, Gonidakis F, Caldas-de-Almeida J, Cardoso G, King MB.

BMC Psychiatry. 2011 Mar 1;11:35. doi: 10.1186/1471-244X-11-35.

50.

Using Lean Six Sigma® Tools to Compare INR Measurements from Different Laboratories Within a Community.

Hurley B, Levett JM, Huber C, Taylor TL.

In: Henriksen K, Battles JB, Keyes MA, Grady ML, editors. Advances in Patient Safety: New Directions and Alternative Approaches (Vol. 3: Performance and Tools). Rockville (MD): Agency for Healthcare Research and Quality (US); 2008 Aug.

Supplemental Content

Loading ...
Support Center